Order Article Reprints

Gmeiner WH, Miller LD, Chou JW, Dominijanni A, Mutkus L, Marini F, Ruiz J, Dotson T, Thomas KW, Parks G, et al. Dysregulated Pyrimidine Biosynthesis Contributes to 5-FU Resistance in SCLC Patient-Derived Organoids but Response to a Novel Polymeric Fluoropyrimidine, CF10. Cancers. 2020; 12(4):788. https://doi.org/10.3390/cancers12040788

Gmeiner, William H., Lance D. Miller, Jeff W. Chou, Anthony Dominijanni, Lysette Mutkus, Frank Marini, Jimmy Ruiz, Travis Dotson, Karl W. Thomas, Graham Parks, and et al. 2020. "Dysregulated Pyrimidine Biosynthesis Contributes to 5-FU Resistance in SCLC Patient-Derived Organoids but Response to a Novel Polymeric Fluoropyrimidine, CF10" Cancers 12, no. 4: 788. https://doi.org/10.3390/cancers12040788

Gmeiner, W. H., Miller, L. D., Chou, J. W., Dominijanni, A., Mutkus, L., Marini, F., Ruiz, J., Dotson, T., Thomas, K. W., Parks, G., & Bellinger, C. R. (2020). Dysregulated Pyrimidine Biosynthesis Contributes to 5-FU Resistance in SCLC Patient-Derived Organoids but Response to a Novel Polymeric Fluoropyrimidine, CF10. Cancers, 12(4), 788. https://doi.org/10.3390/cancers12040788